特素(紫杉醇)治疗晚期恶性肿瘤的临床研究

A Study on Taxol in Advanced Malignant Tumors

摘要: 目的：分析特素治疗31例晚期恶性肿瘤效果。方法：患者接受以特素为主的联合化疗，并给患者标准的抗过敏反应用药。结果：特素治疗疗效为70.96%，主要毒性为骨髓抑制，未发生任何因特素毒性过敏死亡病例。结论：特素对晚期恶性肿瘤的疗效肯定，是目前治疗晚期恶性肿瘤的良好药物。

Abstract: objective:Purpose 31cases of advanced malignant tumor treated by Paclitaxel are reported. Methods :The patients received Taxol containing combination chemotherapy,And standardised anti allergic durgs are used to patient. Results :Good effects of paclitaxel treatment showed 70 96%,Myelosuppresion is the principal toxicity,None case was died of durg allergy.conclusion:Taxol is a drug of choice in the treatment of advanced malignant tumors who are resistant to conventional chemotherapy.